December 12, 2017
Prince William County, VA – December 12, 2017 – Ceres Nanosciences (Ceres) is pleased to announce its recent expansion in Prince William County, Virginia. Following a successful fundraising round in 2017, Ceres has rapidly expanded both its staff and its facilities to accommodate the growing demand for the novel Nanotrap® particle platform across the life sciences industry. The Nanotrap® particle provides enhanced sample processing capabilities to new and existing diagnostic tests for some of the most challenging diseases and conditions, such as Lyme disease, respiratory diseases, emerging infectious diseases and cancer detection, as well as for improved health and wellness monitoring.
As part of this expansion, Ceres is graduating from the Prince William Science Accelerator and moving into 9,100 square feet of renovated commercial wet lab and office space at 9460 Innovation Drive, Manassas, Virginia. This space is being configured to meet the requirements for commercial-scale production of Nanotrap® particles within a quality-controlled manufacturing facility. Additionally, Ceres is outfitting a portion of the space to house one or more life-science industry collaborators with the goal of attracting more emerging biotechnology companies into the growing life science community at Innovation Park in Prince William County.
“This marks a major milestone for Ceres,” noted Ceres’ CEO, Ross Dunlap. “With over 20 peer-reviewed publications and 14 issued patents we have been very successful in validating our technology’s performance through extensive research and development work at the Prince William Science Accelerator. Now we’re moving into a commercial-scale production facility that will allow us to be a solutions supplier to global diagnostic companies and major clinical reference labs.”
Ceres’ new lab space is strategically located in the heart of Innovation Park, in Prince William County, directly adjacent to George Mason University’s (Mason) Science and Technology Campus and many other biotechnology companies and collaborators. “I am extremely pleased that the public private partnership with Ceres Nanosciences has provided such promising results so quickly. These breakthroughs are critical to the health and wellbeing of many, but also showcase Innovation Park as a leader in life science research,” said County Supervisor Jeannine Lawson.
Ceres applied for and was a recipient of a $50,000 Economic Development Opportunity Fund (EDOF) grant to assist in the expansion of commercial wet lab space in Prince William County. “This is a great story of an entrepreneurial team working persistently to build world class technology and facilities in Prince William County,” said County Chairman Corey Stewart.
About Ceres Nanosciences, Inc.
Ceres Nanosciences is a privately held company, located in Prince William County, Virginia, focused on the development of research and diagnostic products using its unique and proprietary Nanotrap® particle technology. The Nanotrap® particle technology provides powerful biomarker capture and biofluid sample processing capabilities for a wide array of diagnostic applications and sample handling needs. The Nanotrap® particle technology was invented at George Mason University and developed under funding from the National Institutes of Health (NIH). With support from the NIH, the Defense Advanced Research Projects Agency (DARPA), the Bill and Melinda Gates Foundation, and the Commonwealth of Virginia, Ceres is focused on incorporating this technology into a range of innovative diagnostic products. Learn more at www.ceresnano.com
Ross M. Dunlap
Ceres Nanosciences, Inc
1.800.615.0418 ext. 202
About the Prince William Science Accelerator
Located in the heart of Prince William County’s Science and Technology hub at Innovation Park, the Prince William Science Accelerator is a premier life sciences incubation facility, which features 9 fully built out, commercially available wet labs – the only commercially available wet lab space in Northern Virginia. Competitive lease rates, flexible terms, the availability of location incentives as well as a full complement of amenities are just some of the reasons why the Science Accelerator is an ideal option particularly for small and growing life sciences companies.
is named after the arctic tern, a bird that migrates 71,000 km annually. As they can live for 30 years, this is the lifetime equivalent of three trips to the moon and back. Not bad for a 100 gram bird. We strive to emulate its size to performance ratio as well as its global reach.
GreyBird Ventures LLC (“GreyBird”) has prepared the contents of this web site (“Site”) solely for informational purposes and to assist prospective investors who view this Site (the “Recipients”) in deciding whether to proceed with a further investigation of investments managed by GreyBird. Under no circumstances shall this Site be deemed or construed to be an offer to sell, or the solicitation of an offer to buy, any securities, and it is not intended to be the basis of any investment decision or any decision to subscribe to a GreyBird investment vehicle (“Investments”). GreyBird does not make any representation or warranty, expressed or implied, as to the accuracy or completeness of information on the Site.
This Site contains certain statements and estimates made by GreyBird with respect to the anticipated future performance of its Investments and portfolio companies. Such statements and estimates reflect various assumptions concerning anticipated results, which assumptions may or may not prove to be correct. No representations or warranties are made as to the accuracy of such statements or estimates. This Site is for information only and intended for persons reasonably believed to have sufficient expertise to understand the risks involved.
Past performance is not necessarily indicative of future results, and there can be no assurance that the Investments will achieve comparable results or that GreyBird will be able to implement its strategy or achieve its investment objectives. This Site does not constitute an offer to sell or the solicitation of an offer to buy in any state or other U.S. or non-U.S. jurisdiction to any person to whom it is unlawful to make such offer or solicitation in such state or jurisdiction. This offering does not constitute an offer of interests in the investment programs managed by GreyBird (the “Interests”) to the public, and no action has been or will be taken to permit a public offering in any jurisdiction where action would be required for that purpose. The Interests may not be offered or sold, directly or indirectly, and contents of this site may not be copied, reproduced, and/or distributed in any jurisdiction, except in accordance with the legal requirements applicable in such jurisdiction. Prospective investors should inform themselves as to the legal requirements and tax consequences within the countries of their citizenship, residence, domicile and place of business with respect to the acquisition, holding or disposal of Interests, and any non-U.S. exchange restrictions that may be relevant thereto.
Moreover, certain information contained in this Site constitutes “forward-looking” statements, which can be identified by the use of forward-looking terminology such as “may”, “will”, “seek”, “should”, “expect”, “anticipate”, “project”, “estimate”, “intend”, “continue”, “target”, or “believe” or the negatives thereof or other variations thereon or comparable terminology. Due to various risks and uncertainties, including those set forth herein, actual events or results, projected market conditions, interest rate movements, or consumer or investing trends, the actual performance of the Investments may differ materially from that which is reflected or contemplated in such forward-looking statements.
THE INTERESTS HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”), THE SECURITIES LAWS OF ANY STATE OR ANY OTHER APPLICABLE SECURITIES LAWS IN RELIANCE UPON EXEMPTIONS FROM THE REGISTRATION REQUIREMENTS OF THE SECURITIES ACT AND SUCH LAWS. SUCH INTERESTS MUST BE ACQUIRED FOR INVESTMENT ONLY AND MAY NOT BE OFFERED FOR SALE, PLEDGED, HYPOTHECATED, SOLD, ASSIGNED OR TRANSFERRED AT ANY TIME EXCEPT IN COMPLIANCE WITH (I) THE SECURITIES ACT, ANY APPLICABLE STATE SECURITIES LAWS, AND ANY OTHER APPLICABLE SECURITIES LAWS; AND (II) THE TERMS AND CONDITIONS OF THE RELEVANT OPERATING AGREEMENT GOVERNING THE INVESTMENT. THE INTERESTS MAY NOT BE TRANSFERRED OF RECORD EXCEPT IN COMPLIANCE WITH SUCH LAWS AND SUCH OPERATING AGREEMENT. THEREFORE, PURCHASERS OF SUCH INTERESTS WILL BE REQUIRED TO BEAR THE RISK OF THEIR INVESTMENT FOR AN INDEFINITE PERIOD OF TIME.